iTolerance (Seed+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$10,000,000
Company Info
Founders
Anthony Japour
Market
Healthcare & Wellness
Company Description

Pioneering regenerative medicine without immunosuppression iTolerance is a biotechnology company focused on regenerative medicine without immunosuppression.